Literature DB >> 25557731

Effect of bilateral carotid body resection on the counterregulatory response to hypoglycaemia in humans.

Erica A Wehrwein1, Jacqueline K Limberg, Jennifer L Taylor, Simmi Dube, Ananda Basu, Rita Basu, Robert A Rizza, Timothy B Curry, Michael J Joyner.   

Abstract

NEW
FINDINGS: What is the central question of this study? Hyperoxia blunts hypoglycaemia counterregulation in healthy adults. We hypothesized that this effect is mediated by the carotid bodies and that: (i) hyperoxia would have no effect on hypoglycaemia counterregulation in carotid body-resected patients; and (ii) carotid body-resected patients would exhibit an impaired counterregulatory response to hypoglycaemia. What is the main finding and its importance? Our data indicate that the effect of hyperoxia on hypoglycaemic counterregulation is mediated by the carotid bodies. However, a relatively normal counterregulatory response to hypoglycaemia in carotid body-resected patients highlights: (i) the potential for long-term adaptations after carotid body resection; and (ii) the importance of redundant mechanisms in mediating hypoglycaemia counterregulation. Hyperoxia reduces hypoglycaemia counterregulation in healthy adults. We hypothesized that this effect is mediated by the carotid bodies and that: (i) hyperoxia would have no effect on hypoglycaemia counterregulation in patients with bilateral carotid body resection; and (ii) carotid body-resected patients would exhibit an impaired counterregulatory response to hypoglycaemia. Five patients (three male and two female) with bilateral carotid body resection for glomus tumours underwent two 180 min hyperinsulinaemic, hypoglycaemic (∼ 3.3 mmol l(-1)) clamps separated by a minimum of 1 week and randomized to either normoxia (21% fractional inspired O2 ) or hyperoxia (100% fractional inspired O2). Ten healthy adults (seven male and three female) served as control subjects. Hypoglycaemia counterregulation in carotid body-resected patients was not significantly altered by hyperoxia (area under the curve expressed as a percentage of the normoxic response: glucose infusion rate, 111 ± 10%; cortisol, 94 ± 6%; glucagon, 107 ± 7%; growth hormone, 92 ± 10%; adrenaline, 89 ± 26%; noradrenaline, 79 ± 15%; main effect of condition, P > 0.05). This is in contrast to previously published results from healthy adults. However, the counterregulatory responses to hypoglycaemia during normoxia were not impaired in carotid body-resected patients when compared with control subjects (main effect of group, P > 0.05). Our data provide further corroborative evidence that the effect of hyperoxia on hypoglycaemic counterregulation is mediated by the carotid bodies. However, relatively normal counterregulatory responses to hypoglycaemia in carotid body-resected patients highlight the importance of redundant mechanisms in mediating hypoglycaemia counterregulation.
© 2014 The Authors. Experimental Physiology © 2014 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25557731     DOI: 10.1113/expphysiol.2014.083154

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  10 in total

1.  Effect of bilateral carotid body resection on cardiac baroreflex control of blood pressure during hypoglycemia.

Authors:  Jacqueline K Limberg; Jennifer L Taylor; Michael T Mozer; Simmi Dube; Ananda Basu; Rita Basu; Robert A Rizza; Timothy B Curry; Michael J Joyner; Erica A Wehrwein
Journal:  Hypertension       Date:  2015-04-13       Impact factor: 10.190

Review 2.  Role of the carotid body chemoreceptors in glucose homeostasis and thermoregulation in humans.

Authors:  Michael J Joyner; Jacqueline K Limberg; Erica A Wehrwein; Blair D Johnson
Journal:  J Physiol       Date:  2018-03-05       Impact factor: 5.182

Review 3.  Glucose, insulin, and the carotid body chemoreceptors in humans.

Authors:  Jacqueline K Limberg
Journal:  Physiol Genomics       Date:  2018-04-13       Impact factor: 3.107

4.  Adrenaline release evokes hyperpnoea and an increase in ventilatory CO2 sensitivity during hypoglycaemia: a role for the carotid body.

Authors:  Emma L Thompson; Clare J Ray; Andrew P Holmes; Richard L Pye; Christopher N Wyatt; Andrew M Coney; Prem Kumar
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

Review 5.  Insulin resistance: a new consequence of altered carotid body chemoreflex?

Authors:  Silvia V Conde; Maria J Ribeiro; Bernardete F Melo; Maria P Guarino; Joana F Sacramento
Journal:  J Physiol       Date:  2016-06-27       Impact factor: 5.182

Review 6.  Carotid body chemoreceptors: physiology, pathology, and implications for health and disease.

Authors:  Rodrigo Iturriaga; Julio Alcayaga; Mark W Chapleau; Virend K Somers
Journal:  Physiol Rev       Date:  2021-02-11       Impact factor: 46.500

Review 7.  G-Protein-Coupled Receptor (GPCR) Signaling in the Carotid Body: Roles in Hypoxia and Cardiovascular and Respiratory Disease.

Authors:  Hayyaf S Aldossary; Abdulaziz A Alzahrani; Demitris Nathanael; Eyas A Alhuthail; Clare J Ray; Nikolaos Batis; Prem Kumar; Andrew M Coney; Andrew P Holmes
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

Review 8.  Carotid Body and Metabolic Syndrome: Mechanisms and Potential Therapeutic Targets.

Authors:  Lenise J Kim; Vsevolod Y Polotsky
Journal:  Int J Mol Sci       Date:  2020-07-20       Impact factor: 5.923

Review 9.  Exploring the Mediators that Promote Carotid Body Dysfunction in Type 2 Diabetes and Obesity Related Syndromes.

Authors:  Joana F Sacramento; Kryspin Andrzejewski; Bernardete F Melo; Maria J Ribeiro; Ana Obeso; Silvia V Conde
Journal:  Int J Mol Sci       Date:  2020-08-03       Impact factor: 5.923

10.  GLP1R Attenuates Sympathetic Response to High Glucose via Carotid Body Inhibition.

Authors:  Audrys G Pauza; Pratik Thakkar; Tatjana Tasic; Igor Felippe; Paul Bishop; Michael P Greenwood; Kristina Rysevaite-Kyguoliene; Julia Ast; Johannes Broichhagen; David J Hodson; Helio C Salgado; Dainius H Pauza; Nina Japundzic-Zigon; Julian F R Paton; David Murphy
Journal:  Circ Res       Date:  2022-02-01       Impact factor: 17.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.